Literature DB >> 10931841

Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation.

S R Eberhardy1, C A D'Cunha, P J Farnham.   

Abstract

Overexpression of c-Myc can lead to altered transcriptional regulation of cellular genes and to neoplastic transformation. Although DNA binding is clearly required, the mechanism by which recruitment of c-Myc to target promoters results in transcriptional activation is highly debated. Much of this controversy comes from the difficulty in clearly defining a true Myc target gene. We have previously determined that cad is a bona fide Myc target gene and thus now use the cad promoter as a model to study Myc function. Others have shown that Myc can interact indirectly with histone acetylases and have suggested that Myc mediates transcriptional activation by causing an increase in the levels of acetylated histones on target promoters. To directly test this model, we employed a chromatin immunoprecipitation assay to examine the levels of acetylated histones on the cad promoter. Although Myc was bound to the cad promoter in S phase but not in G(0) phase, we found high levels of acetylated histones on the promoter in both stages. We also examined acetylated histones on the cad promoter before and after differentiation of U937 cells. Although the levels of c-Myc bound to the cad promoter were greatly reduced after differentiation, we saw high levels of acetylated histones on the cad promoter both before and after differentiation. Finally, we found that a 30-fold change in binding of N-Myc to the telomerase promoter did not result in a concomitant change in histone acetylation. Thus, recruitment of a Myc family member to a target promoter does not necessarily influence the amount of acetylated histones at that promoter. Further investigations are in progress to define the role of Myc in transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931841     DOI: 10.1074/jbc.M005154200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 2.  Disentangling the MYC web.

Authors:  David Levens
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

3.  Use of chromatin immunoprecipitation to clone novel E2F target promoters.

Authors:  A S Weinmann; S M Bartley; T Zhang; M Q Zhang; P J Farnham
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

4.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

Authors:  C Bouchard; O Dittrich; A Kiermaier; K Dohmann; A Menkel; M Eilers; B Lüscher
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

5.  S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells.

Authors:  E J Fox; S C Wright
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

6.  Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.

Authors:  D Xu; N Popov; M Hou; Q Wang; M Björkholm; A Gruber; A R Menkel; M Henriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

7.  Cooperative activities of hematopoietic regulators recruit RNA polymerase II to a tissue-specific chromatin domain.

Authors:  Kirby D Johnson; Jeffrey A Grass; Meghan E Boyer; Carol M Kiekhaefer; Gerd A Blobel; Mitchell J Weiss; Emery H Bresnick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

8.  WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.

Authors:  Caroline Masserot; Qingyuan Liu; Eric Nguyen; Charles-Henry Gattolliat; Dominique Valteau-Couanet; Jean Bénard; Catherine Huber; Evelyne Ségal-Bendirdjian
Journal:  Mol Oncol       Date:  2015-10-21       Impact factor: 6.603

9.  Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis.

Authors:  Peter J Hurlin; Zi-Qiang Zhou; Kazuhito Toyo-oka; Sara Ota; William L Walker; Shinji Hirotsune; Anthony Wynshaw-Boris
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

10.  p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Authors:  Jenny S L Ho; Weili Ma; Daniel Y L Mao; Samuel Benchimol
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.